Price $173.94 |
Market Cap
54.02B
|
Sector Health Care |
Div. Growth
8.70%
|
|
P/E
55.9
|
P/B
10.98
|
P/S
8.84
|
Dividend %
0.40%
|
|
P/CF
780.2
|
P/FCF
53.4
|
Op. Cash Flow
1.42M
|
FCF
3.3
|
|
Op. Margin
20.40%
|
Net Margin
16.10%
|
ROE
20.40%
|
ROI
10.00%
|
|
ROA
9.90%
|
EPS Growth
45.00%
|
Current Ratio
2.3
|
Debt/Equity
46.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Sensus Healthcare Inc (SRTS) | $3.51 | - | - | 60.2M | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $3.71 | - | - | 121M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.80 | - | - | 41.2M | Strong Buy |
| Endo International PLC (ENDP) | $2.83 | - | - | 499.7M | Strong Buy |
| Inogen Inc (INGN) | $49.25 | - | - | 1.36B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
